Literature DB >> 6174049

Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period.

R J Piorkowski, S W Blievernicht, W Lawrence, J Madariaga, J S Horsley, J P Neifeld, J J Terz.   

Abstract

The operative management of 200 patients with pancreatic and periampullary cancer was reviewed. Patients with metastatic disease and biliary obstruction are best treated by the nonoperative techniques of biopsy and internal biliary drainage if technically feasible. For patients who undergo exploration and are found to be candidates for a bypass procedure, both biliary and gastroduodenal bypass should be performed. Lymph node involvement and age of the patient were found to be significant variables in determining the candidates suitable for curative resection. A definite incidence of multicentricity was found in patients undergoing total pancreatectomy for ductal carcinoma of the pancreas; however, significant problems with diabetic management arose from this procedure. The primary site of the lesion as well as the intelligence and socioeconomic background of the patient should dictate the type of resection employed. Pancreatoduodenectomy (Whipple procedure) is recommended for periampullary cancers other than pancreatic carcinoma, while total pancreatectomy may be appropriate in selected patients. However, there has been no evidence thus far in this early trial with total pancreatectomy that more complete resection of the pancreas leads to longer survival.

Entities:  

Mesh:

Year:  1982        PMID: 6174049     DOI: 10.1016/0002-9610(82)90064-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 2.  Current and emerging treatments for pancreatic cancer.

Authors:  W F Regine; W J John; M Mohiuddin
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

3.  Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Authors:  William F Regine; Kathryn A Winter; Ross Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Ann Surg Oncol       Date:  2011-03-10       Impact factor: 5.344

Review 4.  Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

Review 5.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

6.  Management of biliary obstruction in patients with unresectable carcinoma of the pancreas.

Authors:  P C McGrath; P M McNeill; J P Neifeld; H D Bear; G A Parker; M A Turner; J S Horsley; W Lawrence
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

7.  Clinicohistopathologic and immunohistochemical studies of intrapancreatic development of carcinoma of the head of the pancreas.

Authors:  A Nakao; T Ichihara; T Nonami; A Harada; T Koshikawa; N Nakashima; H Nagura; H Takagi
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

8.  Long-term evaluation of pylorus preservation during pancreaticoduodenectomy.

Authors:  A S Fink; L R DeSouza; E A Mayer; R Hawkins; W P Longmire
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

9.  Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial.

Authors:  Yan-Shen Shan; Edgar D Sy; Pin-Wen Lin
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

10.  An original reconstructive method after pylorus-preserving pancreatoduodenectomy.

Authors:  G De Bernardinis; A Agnifili; P Gola; I Ibi; F Gianfelice; G Carducci; R Verzaro
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.